Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK

INTRODUCTION: The results of recently completed cardiovascular outcomes trials in patients with type 2 diabetes mellitus (T2DM) suggest that sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide (GLP) 1 receptor agonists have enhanced cardioprotective properties in patients wit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Diabetes Ther
Asıl Yazarlar: Lautsch, Dominik, Wang, Tongtong, Yang, Lingfeng, Rajpathak, Swapnil N.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Healthcare 2019
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6848348/
https://ncbi.nlm.nih.gov/pubmed/31583647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-019-00698-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller